Bangalore, Karnataka -- (SBWIRE) -- 05/16/2016 -- A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease.

Report forecast the global migraine drugs market to grow at a CAGR of 4.56% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global migraine drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that will be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Migraine Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Allergan
- Endo International
- GlaxoSmithKline
- Impax
- Pfizer

Other prominent vendors
- Abbott
- Aegis Therapeutics
- Aeriel BioPharma
- Alder Biopharmaceuticals
- Amgen
- Astellas
- AstraZeneca
- Bayer
- CoLucid
- Dr. Reddy's Laboratories
- Eisai
- Eli Lilly
- Ethypharm
- IntelGenx
- Johnson & Johnson
- Klaria
- Kowa Pharmaceuticals America
- Luitpold Pharmaceuticals
- Meda
- Merck
- OptiNose
- Pfizer
- Pozen
- Raptor
- RedHill
- SUDA
- Teva
- TG Therapeutics
- NValeant
- Winston Pharmaceuticals
- Zogenix

Market driver
- Growing awareness about migraine and its treatment options
- For a full, detailed list, view our report

Market challenge
- Lack of proper diagnosis
- For a full, detailed list, view our report

Market trend
- Antimigraine devices and headbands
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 63 pages and 27 Exhibits "Global Migraine Drugs Market 2016 - 2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Disease overview, Pipeline analysis, Market landscape, Market segmentation by type of treatment, Market segmentation by therapeutic class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-migraine-drugs-market-2016-2020

Related Reports:

Global Ulcerative Colitis Market 2016-2020 - Visit at - http://www.drugpipeline.net/technavio/global-ulcerative-colitis-market-2016-2020

Global Resipiratory Drugs Market 2016-2020 - Visit at - http://www.drugpipeline.net/technavio/global-resipiratory-drugs-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Contact Us:
Mr. Sudeep Chakravarty
Director - Operations
http://www.drugpipeline.net/
Tel USA: +1-302-703-7787
Tel India: +91-9538405942